SRCL - Stericycle dips 12% on Q1 flat revenue figure

Stericycle (NASDAQ:SRCL -11.7%) shows a marginal drop in Q1 revenues of 0.6% to $664.2M, the decline was led by $13.7M divestiture impact. Organic revenues increased 2.1% with Secure Information Destruction (or SID) organic revenue growing 9.5%.  Income from operations was $5.9M compared to $59.1M last year; reason for the drop being higher revenue cost and higher SGA expenses. CFO was an outflow of $38.8M, compared to an inflow of $62.6M. Non-GAAP EPS of $0.32 and GAAP EPS of loss of -$0.15. 2022 Guidance: Organic revenue growth 3-5% on a base of $2.6B; Adjusted EPS $2.0-$2.3; Free Cash Flow $125M-155M; Capital Expenditures $120M-140M. The stock has declined about 29% over the last one year; taking a comparative rating analysis. Previously: Stericycle Non-GAAP EPS of $0.32, revenue of $664.2M (April 28)

For further details see:

Stericycle dips 12% on Q1 flat revenue figure